See All Slides - tctmd.com

Slides

Presentation TCT 2017

Targets for Device-Based Hypertension Treatments Beyond the Kidneys: Physiology Revisited

Presenter: Elazer R. Edelman, Paul A. Sobotka

October 30, 2017

Presentation TCT 2017

The NOTION 2 Low-risk Trial in Younger Patients

Presenter: Lars Sondergaard

October 30, 2017

Presentation TCT 2017

Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow?

Presenter: Robert A. Byrne, Ran Kornowski, Bernardo Cortese

October 30, 2017

Presentation TCT 2017

Anticipating CoAPT: Two Year Roll-in Results and RCT Progress

Presenter: James B. Hermiller Jr., Ralph Stephan von Bardeleben, Gregg W. Stone

October 30, 2017

Presentation TCT 2017

PQ Bypass and the DETOUR I: 12-Month Results

Presenter: Subhash Banerjee, Jihad A. Mustapha

October 30, 2017

Presentation TCT 2017

How to Guide LAA Closure By ICE

Presenter: Rebecca T. Hahn, Fabian Nietlispach, Brij Maini

October 30, 2017

Presentation TCT 2017

How to Treat the Medina 0,0,1 Lesion

Presenter: Antonio Colombo, Manuel Pan, Angela Hoye

October 30, 2017

Presentation TCT 2017

The Evolut R Low-risk Trial

Presenter: Jeffrey J. Popma

October 30, 2017

Presentation TCT 2017

Malposition of the Evolut R Bioprosthesis During TAVR

Presenter: Mohamed Ahmed Sobhy, Tomasz Gasior

October 30, 2017

Presentation TCT 2017

Switching Between Oral P2Y12 Receptor Inhibitors: When and How?

Presenter: Dominick J. Angiolillo, Marco Valgimigli, Matthew J. Price

October 30, 2017

Advertisement

Slides

Targets for Device-Based Hypertension Treatments Beyond the Kidneys: Physiology Revisited

The NOTION 2 Low-risk Trial in Younger Patients

Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow?

Anticipating CoAPT: Two Year Roll-in Results and RCT Progress

PQ Bypass and the DETOUR I: 12-Month Results

How to Guide LAA Closure By ICE

How to Treat the Medina 0,0,1 Lesion

The Evolut R Low-risk Trial

Malposition of the Evolut R Bioprosthesis During TAVR

Switching Between Oral P2Y12 Receptor Inhibitors: When and How?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content